Nucleic Acids Research, 2000, Vol. 28, No. 24 4884-4892
© 2000 Oxford University Press
Rapid microtiter assays for poxvirus topoisomerase, mammalian type IB topoisomerase and HIV-1 integrase: application to inhibitor isolation
Infectious Disease Laboratory, The Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA
We have developed microtiter assays for detecting catalysis by type IB topoisomerases and retroviral integrases. Each assay employs model DNA substrates containing biotin in one strand and digoxigenin in another. In each case action of the enzyme results in the formation of a single DNA strand containing both groups. This allows the reaction product to be quantified by capturing biotinylated product DNA on avidin-coated plates followed by detection using an anti-digoxigenin ELISA. The order of addition of reactants and inhibitors can be varied to distinguish effects of test compounds on different steps in the reaction. These assays were used to screen compound libraries for inhibitors active against mammalian topoisomerase or HIV integrase. We identified (–)-epigallocatechin 3-O-gallate, as a potent inhibitor of religation by mammalian topoisomerase (IC50 of 26 nM), potentially explaining the anti-cancer properties previously attributed to this compound. New integrase inhibitors were also identified. A similar strategy may be used to develop microtiter assays for many further DNA modifying enzymes.
* To whom correspondence should be addressed. Tel: +1 858 453 4100; Fax: +1 858 554 0341; Email: bushman{at}salk.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Bartholomeeusen, F. Christ, J. Hendrix, J.-C. Rain, S. Emiliani, R. Benarous, Z. Debyser, R. Gijsbers, and J. De Rijck Lens Epithelium-derived Growth Factor/p75 Interacts with the Transposase-derived DDE Domain of PogZ J. Biol. Chem., April 24, 2009; 284(17): 11467 - 11477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hombrouck, B. Van Remoortel, M. Michiels, W. Noppe, F. Christ, A. Eneroth, B. L. Sahlberg, K. Benkestock, L. Vrang, N. G. Johansson, et al. Preclinical Evaluation of 1H-Benzylindole Derivatives as Novel Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Antimicrob. Agents Chemother., August 1, 2008; 52(8): 2861 - 2869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hombrouck, A. Hantson, B. van Remoortel, M. Michiels, J. Vercammen, D. Rhodes, V. Tetz, Y. Engelborghs, F. Christ, Z. Debyser, et al. Selection of human immunodeficiency virus type 1 resistance against the pyranodipyrimidine V-165 points to a multimodal mechanism of action J. Antimicrob. Chemother., June 1, 2007; 59(6): 1084 - 1095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rosenbluh, Z. Hayouka, S. Loya, A. Levin, A. Armon-Omer, E. Britan, A. Hizi, M. Kotler, A. Friedler, and A. Loyter Interaction between HIV-1 Rev and Integrase Proteins: A BASIS FOR THE DEVELOPMENT OF ANTI-HIV PEPTIDES J. Biol. Chem., May 25, 2007; 282(21): 15743 - 15753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hwang, N. Minkah, K. Perry, G. D. Van Duyne, and F. D. Bushman Regulation of Catalysis by the Smallpox Virus Topoisomerase J. Biol. Chem., December 8, 2006; 281(49): 38052 - 38060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bona, M. Andreotti, V. Buffa, P. Leone, C. M. Galluzzo, R. Amici, L. Palmisano, M. G. Mancini, Z. Michelini, R. Di Santo, et al. Development of a human immunodeficiency virus vector-based, single-cycle assay for evaluation of anti-integrase compounds. Antimicrob. Agents Chemother., October 1, 2006; 50(10): 3407 - 3417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bond, Z. Reichert, and J. T. Stivers Novel and Specific Inhibitors of a Poxvirus Type I Topoisomerase Mol. Pharmacol., February 1, 2006; 69(2): 547 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. John, T. M. Fletcher III, and C. B. Jonsson Development and Application of a High-Throughput Screening Assay for HIV-1 Integrase Enzyme Activities J Biomol Screen, September 1, 2005; 10(6): 606 - 614. [Abstract] [PDF]
|
|
|
|
|
|
Y. Wang, H. Klock, H. Yin, K. Wolff, K. Bieza, K. Niswonger, J. Matzen, D. Gunderson, J. Hale, S. Lesley, et al. Homogeneous High-Throughput Screening Assays for HIV-1 Integrase 3{beta}-Processing and Strand Transfer Activities J Biomol Screen, August 1, 2005; 10(5): 456 - 462. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Gao, S. Wong, and F. Bushman Metal Binding by the D,DX35E Motif of Human Immunodeficiency Virus Type 1 Integrase: Selective Rescue of Cys Substitutions by Mn2+ In Vitro J. Virol., July 1, 2004; 78(13): 6715 - 6722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ason and W. S. Reznikoff A high-throughput assay for Tn5 Tnp-induced DNA cleavage Nucleic Acids Res., June 16, 2004; 32(10): e83 - e83. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Svarovskaia, R. Barr, X. Zhang, G. C. G. Pais, C. Marchand, Y. Pommier, T. R. Burke Jr., and V. K. Pathak Azido-Containing Diketo Acid Derivatives Inhibit Human Immunodeficiency Virus Type 1 Integrase In Vivo and Influence the Frequency of Deletions at Two-Long-Terminal-Repeat-Circle Junctions J. Virol., April 1, 2004; 78(7): 3210 - 3222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Vandegraaff, R. Kumar, H. Hocking, T. R. Burke Jr., J. Mills, D. Rhodes, C. J. Burrell, and P. Li Specific Inhibition of Human Immunodeficiency Virus Type 1 (HIV-1) Integration in Cell Culture: Putative Inhibitors of HIV-1 Integrase Antimicrob. Agents Chemother., September 1, 2001; 45(9): 2510 - 2516. [Abstract] [Full Text] [PDF]
|
|